ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

AZYO Aziyo Biologics Inc

1.49
0.00 (0.00%)
26 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Aziyo Biologics Inc NASDAQ:AZYO NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 1.49 1.49 1.53 0 01:00:00

Aziyo Biologics to Present at the Inaugural Gilmartin Group Emerging Growth Company Showcase

17/08/2022 9:05pm

GlobeNewswire Inc.


Aziyo Biologics (NASDAQ:AZYO)
Historical Stock Chart


From Apr 2022 to Apr 2024

Click Here for more Aziyo Biologics Charts.

Aziyo Biologics, Inc. (Nasdaq: AZYO), a commercial-stage regenerative medicine company, today announced the company will present at the upcoming Inaugural Gilmartin Group Emerging Growth Company Showcase, taking place virtually. Members of management are scheduled to present on Wednesday, August 31, 2022 at 10:30 am ET / 7:30 am PT.

Interested parties can access a live webcast of the presentation directly by following this link. An archived webcast of the presentation will be available on the “Investors” section of the Aziyo website at https://investors.aziyo.com/ following the event.

Those parties interested in registering for the Inaugural Gilmartin Group Emerging Growth Company Showcase may do so by following this link.

About Aziyo BiologicsAziyo Biologics is a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, concentrating on patients receiving implantable medical devices. Since its founding in 2015, the Company has created a portfolio of commercial-stage products used in cardiovascular, orthopedic, and reconstructive specialties. For more information, visit www.Aziyo.com.        

Investors:Leigh Salvo Gilmartin Groupinvestors@aziyo.com

Media:Courtney GuyerAziyo Biologics, Inc.PR@aziyo.com

 

1 Year Aziyo Biologics Chart

1 Year Aziyo Biologics Chart

1 Month Aziyo Biologics Chart

1 Month Aziyo Biologics Chart

Your Recent History

Delayed Upgrade Clock